Enteral syringes are used for the administration of medications or feed to patients suffering from chronic illnesses, wherein the patients are unable to ingest food or medicines. Drugs or liquid medications are directly administered in the gastrointestinal tract via enteral syringes. These syringes administer nutritional therapy or medicines to different patient groups including neonates, pediatrics, and adults. Enteral syringes are available in various sizes ranging from 1ml to 60ml and are commonly used for patients in hospitals, clinics, and home care settings. These syringes have a unique design and comprise a purple plunger which indicates that medications are to be delivered through enteral route. It also helps to differentiate from IV syringes.
Increase in premature births resulting in neonatal admissions and rise in prevalence of chronic disorders such as cancer, gastrointestinal diseases, and malnutrition across the globe are the major factors driving the global enteral syringes market. Patients suffering from chronic disorders are admitted to hospitals and critical care units for longer period and are unable to ingest food or medications. According to the Bliss Organization U.K., nearly 95,000 babies are admitted to neonatal care units in the country every year. Furthermore, favorable regulatory guidelines for the design and manufacture of enteral syringes for patient safety are projected to boost the growth of the enteral syringes market during the forecast period. Stay Connected initiative was developed by Global Enteral Device Supplier Association (GEDSA), wherein it introduced the new international standard (ISO 80369-3) called ENFit to reduce the risk of enteral tubing misconnections. Manufacturers are developing enteral syringes that are compatible with ENFit connectors and compliant with the ENFit regulatory guidelines.
The global enteral syringes market can be segmented based on product type, patient group, end-user, and region. In terms of product type, the enteral syringes market can be classified into home use enteral syringes, catheter tip syringes, single use enteral syringes, and others. Based on patient group, the global enteral syringes market can be bifurcated into neonates & pediatrics and adults. The neonates & pediatric segment is projected to grow at a rapid pace during the forecast period owing to increase in premature births across the globe. In terms of end-user, the enteral syringes market can be categorized into hospitals, clinics, and home care settings. The hospitals segment held the largest market share in 2017 and is anticipated to continue to dominate the enteral syringes market during the forecast period.
The global enteral syringes market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for the largest share of the global enteral syringes market between 2018 and 2026. Rise in prevalence of cancer and increase in neonatal admissions are anticipated to drive demand for enteral syringes in the U.S. Adoption of regulatory guidelines for enteral feeding devices including syringes in countries such as the U.K., increase in the geriatric population, and rise in the burden of chronic diseases are anticipated to propel demand for enteral syringes in Europe. Surge in the baby boomer population suffering from chronic ailments and increase in premature births in emerging countries such as India and China are the major factors boosting the growth of the enteral syringes market in Asia Pacific.
Key players operating in the global enteral syringes market are GBUK Enteral Ltd., Cardinal Health, Inc., Koninklijke Philips N.V., Medela LLC, Baxter International, Inc., B. Braun Melsungen AG, Terumo Corporation, NeoMed, Inc., Vygon S.A., Kentec Medical, Inc., and Miktell Ltd. These players have adopted organic and in-organic growth strategies to enhance product portfolio and expand geographic reach.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.